These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 17605105)
1. Reduced brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus. Tahirovic I; Sofic E; Sapcanin A; Gavrankapetanovic I; Bach-Rojecky L; Salkovic-Petrisic M; Lackovic Z; Hoyer S; Riederer P Neurochem Res; 2007 Oct; 32(10):1709-17. PubMed ID: 17605105 [TBL] [Abstract][Full Text] [Related]
2. Brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus. Tahirovic I; Sofic E; Sapcanin A; Gavrankapetanovic I; Bach-Rojecky L; Salkovic-Petrisic M; Lackovic Z; Hoyer S; Riederer P J Neural Transm Suppl; 2007; (72):235-40. PubMed ID: 17982899 [TBL] [Abstract][Full Text] [Related]
3. Antioxidant capacity in rat brain after intracerebroventricular treatment with streptozotocin and alloxan--a preliminary study. Sapcanin A; Sofic E; Tahirovic I; Salkovic-Petrisic M; Hoyer S; Riederer P Neurotox Res; 2008 Apr; 13(2):97-104. PubMed ID: 18515212 [TBL] [Abstract][Full Text] [Related]
4. Streptozotocin produces oxidative stress, inflammation and decreases BDNF concentrations to induce apoptosis of RIN5F cells and type 2 diabetes mellitus in Wistar rats. Bathina S; Srinivas N; Das UN Biochem Biophys Res Commun; 2017 Apr; 486(2):406-413. PubMed ID: 28315336 [TBL] [Abstract][Full Text] [Related]
5. Brain catalase in the streptozotocin-rat model of sporadic Alzheimer's disease treated with the iron chelator-monoamine oxidase inhibitor, M30. Sofic E; Salkovic-Petrisic M; Tahirovic I; Sapcanin A; Mandel S; Youdim M; Riederer P J Neural Transm (Vienna); 2015 Apr; 122(4):559-64. PubMed ID: 25252744 [TBL] [Abstract][Full Text] [Related]
6. Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease? Correia SC; Santos RX; Perry G; Zhu X; Moreira PI; Smith MA Ageing Res Rev; 2011 Apr; 10(2):264-73. PubMed ID: 21262392 [TBL] [Abstract][Full Text] [Related]
7. Protective effect of boldine on oxidative mitochondrial damage in streptozotocin-induced diabetic rats. Jang YY; Song JH; Shin YK; Han ES; Lee CS Pharmacol Res; 2000 Oct; 42(4):361-71. PubMed ID: 10987997 [TBL] [Abstract][Full Text] [Related]
8. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type. Ishrat T; Parveen K; Khan MM; Khuwaja G; Khan MB; Yousuf S; Ahmad A; Shrivastav P; Islam F Brain Res; 2009 Jul; 1281():117-27. PubMed ID: 19374888 [TBL] [Abstract][Full Text] [Related]
9. Characterization of prefrontal cortex microstructure and antioxidant status in a rat model of neurodegeneration induced by aluminium chloride and multiple low-dose streptozotocin. Akinola OB; Biliaminu SA; Adediran RA; Adeniye KA; Abdulquadir FC Metab Brain Dis; 2015 Dec; 30(6):1531-6. PubMed ID: 26307418 [TBL] [Abstract][Full Text] [Related]
10. Taurine attenuates maternal and embryonic oxidative stress in a streptozotocin-diabetic rat model. Shivananjappa MM; Muralidhara Reprod Biomed Online; 2012 May; 24(5):558-66. PubMed ID: 22414371 [TBL] [Abstract][Full Text] [Related]
11. 7,8-Dihydroxyflavone improves cognitive functions in ICV-STZ rat model of sporadic Alzheimer's disease by reversing oxidative stress, mitochondrial dysfunction, and insulin resistance. Akhtar A; Dhaliwal J; Sah SP Psychopharmacology (Berl); 2021 Jul; 238(7):1991-2009. PubMed ID: 33774703 [TBL] [Abstract][Full Text] [Related]
12. NO-Dependent Akt Inactivation by S-Nitrosylation as a Possible Mechanism of STZ-Induced Neuronal Insulin Resistance. Crunfli F; Mazucanti CH; de Moraes RCM; Costa AP; Rodrigues AC; Scavone C; TorrĂ£o AS J Alzheimers Dis; 2018; 65(4):1427-1443. PubMed ID: 30149447 [TBL] [Abstract][Full Text] [Related]
13. Determination of the Best Concentration of Streptozotocin to Create a Diabetic Brain Using Histological Techniques. Dehghan-Shasaltaneh M; Naghdi N; Choopani S; Alizadeh L; Bolouri B; Masoudi-Nejad A; Riazi GH J Mol Neurosci; 2016 May; 59(1):24-35. PubMed ID: 26790434 [TBL] [Abstract][Full Text] [Related]
14. Streptozotocin-induced hippocampal astrogliosis and insulin signaling malfunction as experimental scales for subclinical sporadic Alzheimer model. Rostami F; Javan M; Moghimi A; Haddad-Mashadrizeh A; Fereidoni M Life Sci; 2017 Nov; 188():172-185. PubMed ID: 28867578 [TBL] [Abstract][Full Text] [Related]
15. Prenatal stress promotes icv-STZ-induced sporadic Alzheimer's pathology through central insulin signaling change. Rostami F; Javan M; Moghimi A; Haddad-Mashadrizeh A; Fereidoni M Life Sci; 2020 Jan; 241():117154. PubMed ID: 31857087 [TBL] [Abstract][Full Text] [Related]
16. S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type. Javed H; Khan MM; Khan A; Vaibhav K; Ahmad A; Khuwaja G; Ahmed ME; Raza SS; Ashafaq M; Tabassum R; Siddiqui MS; El-Agnaf OM; Safhi MM; Islam F Brain Res; 2011 May; 1389():133-42. PubMed ID: 21376020 [TBL] [Abstract][Full Text] [Related]
17. Establishment of a rat model of type II diabetic neuropathic pain. Dang JK; Wu Y; Cao H; Meng B; Huang CC; Chen G; Li J; Song XJ; Lian QQ Pain Med; 2014 Apr; 15(4):637-46. PubMed ID: 24716590 [TBL] [Abstract][Full Text] [Related]
18. Intracranial Transplantation of Pancreatic Islets Attenuates Cognitive and Peripheral Metabolic Dysfunctions in a Rat Model of Sporadic Alzheimer's Disease. Bloch K; Gil-Ad I; Vanichkin A; Hornfeld SH; Taler M; Dar S; Azarov D; Vardi P; Weizman A J Alzheimers Dis; 2018; 65(4):1445-1458. PubMed ID: 30175977 [TBL] [Abstract][Full Text] [Related]
19. A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia. Agrawal R; Tyagi E; Shukla R; Nath C Neuropharmacology; 2009 Mar; 56(4):779-87. PubMed ID: 19705549 [TBL] [Abstract][Full Text] [Related]